AIXTRON Announces New Order for MOCVD Reactors from Aqualite

AIXTRON AG today announced a new order for MOCVD reactors from LED power chip expert and existing customer Aqualite Co. Ltd.

The order comprises six CRIUS 31x2-inch configuration deposition systems. The China based company placed the order during the second quarter of 2010 and after delivery of the systems in the current quarter, they will be used for high-power LED production.

The new reactors will be commissioned by the local AIXTRON support team in Aqualite’s dedicated facility at its mainland China production plant.

Dr James Dong, CEO of Aqualite, comments, “We have been very satisfied with our three existing reactors as they are perfectly matching our requirements. However, we now have to increase our production capacity for high-power LEDs. AIXTRON has always been very helpful to us and hence we look forward to receiving these new CRIUS systems. Our systems have delivered on their performance promise – AIXTRON engineering means they have superior specification on all counts but particularly in uniformity and yield. The quality of their engineering and the know-how of their local support team are first-class.”

Source: http://www.aixtron.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AIXTRON SE. (2019, February 13). AIXTRON Announces New Order for MOCVD Reactors from Aqualite. AZoNano. Retrieved on October 31, 2024 from https://www.azonano.com/news.aspx?newsID=20740.

  • MLA

    AIXTRON SE. "AIXTRON Announces New Order for MOCVD Reactors from Aqualite". AZoNano. 31 October 2024. <https://www.azonano.com/news.aspx?newsID=20740>.

  • Chicago

    AIXTRON SE. "AIXTRON Announces New Order for MOCVD Reactors from Aqualite". AZoNano. https://www.azonano.com/news.aspx?newsID=20740. (accessed October 31, 2024).

  • Harvard

    AIXTRON SE. 2019. AIXTRON Announces New Order for MOCVD Reactors from Aqualite. AZoNano, viewed 31 October 2024, https://www.azonano.com/news.aspx?newsID=20740.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.